55
Participants
Start Date
September 1, 2021
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
MR-scans using a 3T Prisma and a 7T Terra scanner (Siemens, Erlangen Germany)
The MR-scans performed at 3T and 7T are performed to evaluate whether high field MR-examinations bring an advantage to the patient in determining the IDH-status of the glioma. Two MRSI/CEST sequences will be tested against each other.
RECRUITING
Institute for Diagnostic and Interventional Neuroradiology, University Hospital Bern, Bern
Swiss National Science Foundation
OTHER
Insel Gruppe AG, University Hospital Bern
OTHER